| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artificial intelligence for breast cancer screening: breathtaking results and a word of caution
|
Segnan, Nereo
|
|
|
24 |
8 |
p. 830-832
|
artikel
|
| 2 |
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study
|
Lång, Kristina
|
|
|
24 |
8 |
p. 936-944
|
artikel
|
| 3 |
Aspartame: it is the risk that matters, not the hazard
|
McConway, Kevin
|
|
|
24 |
8 |
p. 824-825
|
artikel
|
| 4 |
Biomarker tests for targeted oncology therapies pose tricky regulatory challenges
|
Senior, Kathryn
|
|
|
24 |
8 |
p. 839
|
artikel
|
| 5 |
2020 cancer incidence data in the USA reveal effects of the COVID-19 pandemic
|
Townsend, Julie S
|
|
|
24 |
8 |
p. 825-826
|
artikel
|
| 6 |
Carcinogenicity of aspartame, methyleugenol, and isoeugenol
|
Riboli, Elio
|
|
|
24 |
8 |
p. 848-850
|
artikel
|
| 7 |
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment
|
Han, Xuesong
|
|
|
24 |
8 |
p. 855-867
|
artikel
|
| 8 |
Climate change and skin cancer: urgent call for action
|
The Lancet Oncology,
|
|
|
24 |
8 |
p. 823
|
artikel
|
| 9 |
Common Sense Oncology: outcomes that matter
|
Booth, Christopher M
|
|
|
24 |
8 |
p. 833-835
|
artikel
|
| 10 |
Correction to Lancet Oncol 2023; 24: 868–80
|
|
|
|
24 |
8 |
p. e328
|
artikel
|
| 11 |
Correction to Lancet Oncol 2023; 24: 611–23
|
|
|
|
24 |
8 |
p. e328
|
artikel
|
| 12 |
Correction to Lancet Oncol 2023; published online July 13. https://doi.org/10.1016/S1470-2045(23)00342-X
|
|
|
|
24 |
8 |
p. e328
|
artikel
|
| 13 |
Decentralised, point-of-care CAR-T for multiple myeloma
|
Anguille, Sébastien
|
|
|
24 |
8 |
p. 828-830
|
artikel
|
| 14 |
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
|
Pasquier, David
|
|
|
24 |
8 |
p. e331-e343
|
artikel
|
| 15 |
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial
|
Nutting, Christopher
|
|
|
24 |
8 |
p. 868-880
|
artikel
|
| 16 |
Egypt launches 100 Healthy Days health-care campaign
|
Das, Manjulika
|
|
|
24 |
8 |
p. 845
|
artikel
|
| 17 |
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
|
Pant, Shubham
|
|
|
24 |
8 |
p. 925-935
|
artikel
|
| 18 |
Establishing a Lancet Oncology Commission on the humanitarian crisis of cancer
|
Rodin, Gary
|
|
|
24 |
8 |
p. 835-837
|
artikel
|
| 19 |
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
|
Oliver-Caldés, Aina
|
|
|
24 |
8 |
p. 913-924
|
artikel
|
| 20 |
Growing liver cancer death rates in the UK call for healthier lifestyle choices
|
Gourd, Elizabeth
|
|
|
24 |
8 |
p. e329
|
artikel
|
| 21 |
ICGC ARGO precision medicine: genomic profiling-informed prediction of immunotherapy response in two patients with metastatic head and neck squamous cell carcinoma
|
Nocini, Riccardo
|
|
|
24 |
8 |
p. 851-853
|
artikel
|
| 22 |
Improving cancer outcomes in low-income areas in the USA
|
Makoni, Munyaradzi
|
|
|
24 |
8 |
p. 841
|
artikel
|
| 23 |
Improving functional outcomes for patients with head and neck cancer
|
Nuyts, Sandra
|
|
|
24 |
8 |
p. 827-828
|
artikel
|
| 24 |
Metastatic seminoma masquerading as sarcoidosis
|
Shopsowitz, Kevin E
|
|
|
24 |
8 |
p. e355
|
artikel
|
| 25 |
Middle-age lung screening for everyone who has smoked
|
Gourd, Elizabeth
|
|
|
24 |
8 |
p. 838
|
artikel
|
| 26 |
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities
|
Kim, Michelle M
|
|
|
24 |
8 |
p. e344-e354
|
artikel
|
| 27 |
NCRI stuns cancer trial researchers with closure announcement
|
Wilkinson, Emma
|
|
|
24 |
8 |
p. 840
|
artikel
|
| 28 |
NHS embraces AI-assisted radiotherapy technology
|
Senior, Kathryn
|
|
|
24 |
8 |
p. e330
|
artikel
|
| 29 |
NHS England ends treatment break rule in bowel cancer
|
Senior, Kathryn
|
|
|
24 |
8 |
p. 842
|
artikel
|
| 30 |
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
|
Blay, Jean-Yves
|
|
|
24 |
8 |
p. 892-902
|
artikel
|
| 31 |
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
|
Albiges, Laurence
|
|
|
24 |
8 |
p. 881-891
|
artikel
|
| 32 |
Projected rise in cancer cases in France
|
Casassus, Barbara
|
|
|
24 |
8 |
p. 844
|
artikel
|
| 33 |
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed
|
Jena, Rahul
|
|
|
24 |
8 |
p. e324
|
artikel
|
| 34 |
Radical cystectomy vs trimodality therapy for muscle-invasive bladder cancer: further extensive evaluation needed – Authors' reply
|
Zlotta, Alexandre R
|
|
|
24 |
8 |
p. e325-e326
|
artikel
|
| 35 |
Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030
|
Rosa, Arthur Accioly
|
|
|
24 |
8 |
p. 903-912
|
artikel
|
| 36 |
Retraction and republication—Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
|
|
|
|
24 |
8 |
p. 832
|
artikel
|
| 37 |
Retraction and republication—TRICOTEL: defining symptomatic brain metastases in clinical trials
|
Dummer, Reinhard
|
|
|
24 |
8 |
p. e327
|
artikel
|
| 38 |
South Korea backs Japanese plan to release Fukushima waste water
|
Das, Manjulika
|
|
|
24 |
8 |
p. 847
|
artikel
|
| 39 |
The post-truth anti-science era: what and who can we trust?
|
Morgan, Jules
|
|
|
24 |
8 |
p. 853-854
|
artikel
|
| 40 |
UK–BioNTech partnership for mRNA cancer vaccines
|
Wilkinson, Emma
|
|
|
24 |
8 |
p. 846
|
artikel
|
| 41 |
US Supreme Court ruling on affirmative action impacts oncology
|
Das, Manjulika
|
|
|
24 |
8 |
p. 843
|
artikel
|
Tijdschrift beschrijving